Dr. George L. Alcorn, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1373 E State Road 62, Madison, IN 47250 Phone: 812-801-0828 Fax: 812-801-0344 |
News Archive
Mayo Clinic researchers have shown a link between which type of oral anticoagulant (blood-thinning medication) a patient takes to prevent a stroke and increased risks of kidney function decline or failure.
Ligand Pharmaceuticals Incorporated announced today that its partner Pfizer, Inc. has granted a sublicense to a multi-national pharmaceutical company for Tanaproget, also known as NSP-989. As a result, Ligand will receive an upfront payment of $1 million from Pfizer. Ligand is entitled to clinical and regulatory milestone payments from Pfizer as Tanaproget advances through the development process, as well as tiered royalties on net sales.
Working out just became a whole lot easier with PumpOne's 2012 personal training experience. Launching across all major platforms for both consumers and professionals, the state-of-the-art FitnessBuilder is now available on the Web at www.fitnessbuilder.com and the Android Market in addition to its already massively successful iOS app for iPhone, iPad, and iPod touch.
The Coalition for Pulmonary Fibrosis and the Pulmonary Fibrosis Foundation are applauding the efforts of Pulmonary Fibrosis (PF) patients and family members for their work to convey to the FDA and an FDA Advisory Committee the sense of urgency and desperation regarding the disease and the lack of treatment options.
› Verified 3 days ago